Please login to read the full article.
Scrip Regulatory Affairs
FDA report questions whether US rules can ensure quality of marketed medical devices
22 November 2011
Vibha Sharma
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- US FDA action on drug shortages yields results, agency improves user fee goals
- French bill tightens up on safety and conflicts of interest, but not drug approval criteria
- US FDA sets 30 June deadline for finalising companion diagnostics guidance; publishes other device priorities
- US FDA funds remain level in Obama FY 2013 budget
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
